Table 3.
Clinical characteristics of patients with positive and negative CUS during hospitalization. Data are reported as mean ± SD for continuous variables and % for categorical variables
| Negative Proximal Cus | Positive Proximal Cus | P | |
|---|---|---|---|
| N | 1776 | 64 | - |
| Age (years) | 71 ± 16 | 75 ± 13 | 0.03 |
| Age > 70 years, n (%) | 1046 (59%) | 46 (71,9%) | 0.038 |
| Female, n (%) | 928 (52%) | 31 (48%) | 0.515 |
| BMI (kg/m2) | 27 ± 5 | 25 ± 4 | 0.04 |
| Current Smoking, n (%) | 392 (22%) | 16 (25%) | 0.581 |
| Diabetes, n (%) | 458 (26%) | 13 (20%) | 0.324 |
| Hypertension, n (%) | 1115 (62%) | 36 (56%) | 0.289 |
| Myocardial infarction or STROKE, n (%) | 268 (15%) | 4 (6%) | 0.05 |
| Acute infection, n (%) | 577 (32%) | 27 (42%) | 0.105 |
| Pneumonia, n (%) | 262 (15%) | 11 (17%) | 0.62 |
| Active Cancer, n (%) | 267 (15%) | 19 (30%) | 0.001 |
| Previous VTE, n (%) | 67 (3,7%) | 5 (7.8%) | 0.257 |
| Reduced mobility, n (%) | 501 (28%) | 25 (40%) | 0.06 |
| Thrombophilia, n (%) | 14 (0,7%) | 4 (6.2%) | < 0.0001 |
| Kidney failure, n (%) | 359 (20%) | 10 (15.6%) | 0.368 |
| Heart or respiratory failure, n (%) | 419 (23%) | 21 (32.8%) | 0.09 |
| IMPROVE-DDa | 2.3 + 1.6 | 3.9 + 1.6 | < 0.0001 |
| D-dimer (µg/mL)a | 1,52 ± 1,425 | 3,28 ± 1,39 | < 0.0001 |
aPerformed only in patients where D-Dimer has been evaluated